Study of adiponectin level in diabetic adolescent girls in relation to glycemic control and complication of diabetes

Open Access Macedonian Journal of Medical Sciences

Volumn 3, Issue 4, 2015, Pages 613-618

  Abd El Dayem, Soha M ^a   Nazif, Hayam K ^b   Ei Kader, Mone Abd ^a   El Tawil, Maha ^c  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Police Authority Hospital   (Egypt)

Author keywords

Adiponectin; Complication; Glycemic control; Type 1 diabetes

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; OBSERVATIONAL STUDY; SYSTOLIC BLOOD PRESSURE; TURBIDIMETRY; URINALYSIS;

EID: 85027395481     PISSN: None     EISSN: 18579655     Source Type: Journal    
DOI: 10.3889/oamjms.2015.098     Document Type: Article

References (37)

1. Esposito K, Pantillo A, Di-Palo C. Effects of weight loss and life style changes on vascular inflammatory markers in obese women. J Am Med Assoc. 2003; 289: 1799-1804. http://dx.doi.org/10.1001/jama.289.14.1799 PMid:12684358
2. Pankowska E, Szalecki M. Adiponectin as an adipose tissue hormone. Endokrynol Diabetol Chor. 2005; 11(3): 187-90.
3. Aygun C, Senturk O, Hulogu S, Uraz S, Celebi A. Serum levels of hepatoprotective adiponectin in non alcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2006; 18(2): 175-80. http://dx.doi.org/10.1097/00042737-200602000-00010 PMid:16394799
4. Celi F, Bini V, Papi F, Santilli E, Castellani MS, Ferretti A, Mencacci M, Berioli MG, De Giorgi G, Falorni A. Circulating adipocytokines in non-diabetic and type 1 diabetic children: relationship to insulin therapy, glycemic control and pubertal development. Diabet Med. 2006; 23: 660–665. http://dx.doi.org/10.1111/j.1464-5491.2006.01823.x PMid:16759309
5. Furuta M, Tarnai M, Hanabusa T. Serum adiponectin is associated with fasting C peptide in non-obese diabetic patients. Diabetes Res Clin Prac. 2006; 72(3):302-7. http://dx.doi.org/10.1016/j.diabres.2005.10.026 PMid:16442181
6. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care; 2013; 34 (1): S1:62.
7. Aboul Ella NA, Shehab DI, Ismail MA, Maksoud AA. Prevalence of metabolic syndrome and insulin resistance among Egyptian adolescents 10 to 18 years of age. J Clin Lipitol. 2010; 4 (3): 185–95. http://dx.doi.org/10.1016/j.jacl.2010.03.007 PMid:21122651
8. Karamifar H, Habibian N, Amirhakimi G, Karamizadeh Z, Alipour A. Adiponectin is a Good Marker for Metabolic State among Type 1 Diabetes Mellitus Patients. Iran J Pediatr. 2013; 23(3):295-301. PMid:23795252 PMCid:PMC3684474
9. Charles M, Soedamah-Muthu SS, Tesfaye S, Fuller JH, Arezzo JC, Chaturvedi N, Witte DR. Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care. 2010; 33:2648-2653. http://dx.doi.org/10.2337/dc10-0456 PMid:20823346 PMCid:PMC2992206
10. Roy MS. Diabetic retinopathy in African Americans with type 1 diabetes: Methodology, population, frequency of retinopathy, and visual impairment. Arch Ophthalmol. 2000; 118:97-104. http://dx.doi.org/10.1001/archopht.118.1.97 PMid:10636422
11. Flegg HM. An investigation for the determination of serum cholesterol by an enzymatic method. Ann Clin Biochem. 1973;10:79–84. http://dx.doi.org/10.1177/000456327301000125
12. Marques-Vidal P, Ferrario M, Kuulasmaa K, Grafnetter D, Moltchanov V, for the WHO MONICA Project. Quality assessment of data on HDL cholesterol in the WHO MONICA Project (1999). Available at: URL: http://www.thl.fi/publications/monica/hdl/hdlqa.htm,URN:NBN:fi-fe19991137.
13. Castillo E, Montes-Bayon M, Anon E, Sanz-Medel A. Quantitative targeted biomarker assay for glycated haemoglobin by multidimensional LC using mass spectrometric detection. J Proteomics. 2010; 74(1):35-43. http://dx.doi.org/10.1016/j.jprot.2010.07.011 PMid:20691816
14. Miller WG, Bruns DE, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, Itoh Y, Lieske JC, Seccombe DW, Jones G, Bunk DM, Curhan GC, Narva AS. National Kidney Disease Education Program-IFCC Working Group on Standardization of Albumin in Urine. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem. 2009; 55(1):24-38. http://dx.doi.org/10.1373/clinchem.2008.106567 PMid:19028824
15. Ebinuma H, Miyazaki O, Yago H, Hara K, Yamauchi T, Kadowaki TA. Novel ELISA system for selective measurement of human Adiponectin multimers by using proteases. Clin Chim Acta. 2006; 372:47-53. http://dx.doi.org/10.1016/j.cca.2006.03.014 PMid:16697359
16. Barnes MM, Curran-Everett D, Hamman RF, Maahs D, Mayer-Davis EJ, D'Agostino RB Jr, West N, Dabelea D. Determinants of adiponectin levels in young people with type 1 diabetes. Diabet Med. 2008; 25:365-369. http://dx.doi.org/10.1111/j.1464-5491.2007.02374.x PMid:18307464
17. Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T and Kiess W: Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control. Eur J Endocrinol. 2007; 157:481-489. http://dx.doi.org/10.1530/EJE-07-0250 PMid:17893263
18. Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M. Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care. 2004; 27:2010-14. http://dx.doi.org/10.2337/diacare.27.8.2010 PMid:15277432
19. Goksen D, Levent E, Kar S, Ozen S, Darcan N. Serum Adiponectin and hsCRP Levels and Noninvasive Radiological Methods in the Early Diagnosis of Cardiovascular System Complications in Children and Adolescents with Type 1 Diabetes Mellitus. J Clin Res Pediatr Endocrinol. 2013; 5(3): 174-181. http://dx.doi.org/10.4274/Jcrpe.1003 PMid:24072086 PMCid:PMC3814533
20. Li S, Shin H, Ding E, van-Dam R. Adiponectin levels and risk of type 2 diabetes. JAMA. 2009; 302: 179-188. http://dx.doi.org/10.1001/jama.2009.976 PMid:19584347
21. Messaaoui A, Willems D, Melot C, Dorchy H. Risk markers for cardiovascular disease in young type 1 diabetic patients: Lipoproteins, high sensitivity C-reactive protein and adiponectin. Acta Clinica Belgica. 2012; 67: 2-16.
22. Patel JV, Abraheem A, Dotsenko O, Creamer J, Gunning M, Hughes EA and Lip GY: Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. J Intern Med. 2008; 264(6): 593-8. http://dx.doi.org/10.1111/j.1365-2796.2008.02007.x PMid:18793246
23. Maahs DM, Dabelea D, D'Agostino RB Jr, Andrews JS, Shah AS, Crimmins N, Mayer-Davis EJ, Marcovina S, Imperatore G, Wadwa RP, Daniels SR, Reynolds K, Hamman RF, Dolan LM. Glucose control predicts 2 year change in lipid profile in youth with type 1 diabetes: Search for diabetes in youth study. J Pediatr. 2013; 162 (1): 101-107. http://dx.doi.org/10.1016/j.jpeds.2012.06.006 PMid:22795314 PMCid:PMC3807690
24. Habeeb NM, Youssef OI, Saab AA, EI Hadidi E. S. Adiponectin as a marker of complications in children with type I diabetes. Indian Pediatr. 2012; 49(4):277-80. http://dx.doi.org/10.1007/s13312-012-0041-5 PMid:21992860
25. Wang Y, Xu A, Knight C, Xu LY, Cooper GJ: Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J BioI Chem. 2002; 277(22):19521-9. http://dx.doi.org/10.1074/jbc.M200601200 PMid:11912203
26. Lindstrom T, Frystyk J, Hedman CA, Flyvbjerg A, Arnqvist HJ. Elevated circulating adiponectin in type 1 diabetes associated with long diabetes duration. Clin Endocrinol. 2006; 65 :776-782. http://dx.doi.org/10.1111/j.1365-2265.2006.02666.x PMid:17121530
27. Hadjadj S, Aubert R, Fumeron F, Pean F, Tichet J, Roussel R: Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia. 2005; 48: 1 088-1092.
28. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ. 2004; 328 (7448): 1105. http://dx.doi.org/10.1136/bmj.38070.450891.FE PMid:15096438 PMCid:PMC406322
29. Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess. 2005; 9(30): 163. http://dx.doi.org/10.3310/hta9300
30. EI-Mesallamy HO, Hamdy NM, Ibrahim SM. Adiponectin and pro-inflammatory cytokines in obese diabetic boys. Indian Pediatr. 2011; 48: 118-31.
31. Frank RN. Diabetic retinopathy. N Engl J Med. 2004; 350(1):48-58. http://dx.doi.org/10.1056/NEJMra021678 PMid:14702427
32. Zietz B, Buechler C, Kobuch K, Neumeier M, Scholmerich J, Schaffler A. Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes. 2008; 116: 532-536. http://dx.doi.org/10.1055/s-2008-1058086 PMid:18680072
33. Yilmaz MI, Sonmez A, Acikel C, Celik T, Bingol N, Pinar M. Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol. 2004; 151: 135-140. http://dx.doi.org/10.1530/eje.0.1510135 PMid:15248834
34. Horta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc BioI. 2002; 20: 1595-1599.
35. Nagaoka T, Sato E, Takahashi A, Yokota H, Sogawa K, Yoshida A. Impaired retinal circulation in patients with type 2 diabetes mellitus: retinal laser Doppler velocimetry study. Invest Ophthalmol Vis Sci. 2010; 51: 6729-6734. http://dx.doi.org/10.1167/iovs.10-5364 PMid:20631236
36. Fan X, Wu Q, Li Y, Hao Y, Ning N, Kang Z, Cui Y, Liu R, Han L. Association between adiponectin concentrations and diabetic retinopathy in patients with type 2 diabetes: a meta-analysis. Chin Med Jn. 2014; 127(4):765-71.
37. Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I. Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb. 2011; 18(7):592-5. http://dx.doi.org/10.5551/jat.7625 PMid:21378472